PRICKLE2 and breast carcinoma: Using cfMethylPre, we identified and validated three novel genes—PCDHA10, PRICKLE2, and PRTG—that exhibit inhibitory effects on breast cancer cell proliferation and migration, highlighting its potential in precision oncology.